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Abstract
Background: Past work on asthmatic African American families revealed a strong linkage peak
with modest evidence of association on chromosome 11q. Here, we perform tests of association
for asthma and a panel of 609 SNPs in African American subjects using a sliding window approach.
While efficient in screening a region of dense genotyping, this approach does create some
problems: high numbers of tests, assimilating thousands of results, and questions about setting
priorities on regions with association signals.
Results: We present a newly developed tool, Graphical Assessment of Sliding P-values or GrASP,
which uses color display to indicate the width of the sliding windows, significance of individual tests,
density of SNP coverage and location of known genes that simplifies some of these issues, and use
it to identify regions of interest in these data.
Conclusion: We demonstrate that GrASP makes it easier to visualize, summarize and prioritize
regions of interest from sliding window haplotype analysis, based jointly on the p-value from all the
tests from these windows and the building of haplotypes of significance in the region. Using this
approach, five regions yielded strong evidence for linkage and association with asthma, including
the prior peak linkage region.
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Background
To search for causal genes for asthma on chromosome
11q, a region previously highlighted in linkage and asso-
ciation studies on African American families by our group,
a dense panel of SNPs was genotyped using an Illumina™
fine mapping panel in these African American subjects.
The sliding window approach that has gained much favor
in recent years [1-6] to test for association between SNPs
and haplotypes in this region was adapted to analyze case-
parent trios and case-control data because it is a simple
and efficient way to screen a region of dense genotyping.
Given an ordered set of markers (1, 2, 3,....n), sliding win-
dows of overlapping haplotypes are tested in sequence,
i.e. markers 1-2-3 are treated as a single haplotype, then
markers 2-3-4 are treated as a single haplotype, then mark-
ers 3-4-5, etc. Haplotypes of varying sizes (i.e. 2-, 3-, 4-
SNP haplotypes, etc.) can be assessed. When large num-
bers of SNPs are used, this approach generates large num-
bers of non-independent statistical tests, and visualizing
and interpreting these multiple tests can become daunt-
ing. Currently, it is common practice to use some form of
summary measure (such as the minimum p-value of all
sliding windows or windows of a particular size that
include any one SNP) as a synopsis of each SNP. Here, we
present a novel tool called Graphical Assessment of Slid-
ing P-values or GrASP that provides a graphical overview
of all tests from sliding windows without sub selection.
Asthma, a disease of chronic airway inflammation, shows
strong familial aggregation [7-9] but models of inherit-
ance are inconsistent, and linkage studies over the past
decade have suggested that causal genes may be located
on over two dozen chromosomal regions [10,11]. Heter-
ogeneity in the genetic control of asthma is obvious from
the variable evidence for linkage and/or association across
studies and even among families within a single study.
Recently, positional cloning studies have identified four
novel candidate genes for asthma, including the genes
encoding PDH finger protein 11 (PHF11) on chromo-
some 13q14 [12] dipeptidyl peptidase IV-related protein
3 (DPP10) on chromosome 2q14-q32 [13], a disintegrin
and metalloproteinase domain 33 (ADAM33) on chro-
mosome 20p13 [14], and G protein-coupled receptor for
asthma susceptibility (GPRA) on 7p [15].
In a genome-wide scan and subsequent fine-mapping
analysis, we have previously presented evidence of linkage
of asthma to chromosome 11q markers in an African
American population, but not Caucasian or Hispanic fam-
ilies [16,17]. Further, family based association and trans-
mission disequilibrium tests (TDT) showed significant
evidence of linkage and linkage disequilibrium for several
individual markers in this region. A putative susceptibility
locus was estimated to be at map position 70.8 cM with a
confidence interval spanning the linkage peak [17]. Sev-
eral candidate genes in this region were examined for
association with asthma: CRTH2, which encodes a recep-
tor for prostaglandin D2 (PGD2) [18]; FCER1B, encoding
the high affinity IgE receptor β subunit [19]; and CC10,
the Clara cell 10-kD immunomodulator [20]. Family-
based and case-control analysis of asthma and two com-
mon SNPs (G1544C and G1651A) in the 3' untranslated
region of CRTH2 showed significant evidence of linkage
in the presence of disequilibrium in this African American
and an independent Chinese population [21]. Here, we
present further fine-mapping of this region on 11q in the
African American families and apply GrASP to these data
to illustrate its ability to summarize results from thou-
sands of tests while identify regions of interest based on
all single-SNP and haplotype tests of association.
Results
Samples were genotyped at the SNP Center of the Genetic
Resources Core Facility (GRCF) using the Illumina™ Fine
Mapping Panel #38 spanning 52 Mb on chromosome
11q. The GRCF released genotypes on a total of 705 loci;
the overall error rate for the entire data set was 0.55 %
(considering duplicated samples – 46 events/8,410 geno-
types) and the overall parent-child discordance rate was
0.07 % (4 events/5,612 genotypes). An additional 36 loci
had minor allele frequencies < 5%, 8 had 50% Gencall
scores < 0.40 [22], 18 markers had reproducibility
between the duplicate samples (6 comparison pairs) of <
100%, 7 had Mendelian inconsistencies in families > 2%,
and 43 showed significant departure from Hardy Wein-
berg Equilibrium (p-value < 0.01).
The final data for the family-based analysis included 86
probands, 63 fathers and 75 mothers from the 89 nuclear
families resulting in 60 child-father pairs, 73 child-mother
pairs or 51 complete trios. The case-control analysis for
replication included the 86 probands and 94 control sam-
ples. A total of 609 markers on 318 samples were used in
the analyses, with an average distance between SNPs of
86119 bp (range: 127 – 3676182 bp). Average linkage dis-
equilibrium (LD) between neighboring SNPs was modest
with an average D' = 0.53 and average r2 = 0.11.
Single SNP results
A total of 48 SNPs had p-values < 0.05 in the case-control
data and 34 in the family data (6 of which were significant
in both data sets). Table 1 presents results for these 6 com-
mon SNPs, and for 20 SNPs that had p-values < 0.01 in
either the case-control or family data, along with the
known genes where they are located.
Selecting regions for haplotype analysis
Considering 609 SNPs and sliding window sizes from 2 –
6 SNPs per window, there are 3030 non-independent tests
for each study design (608 2-SNP windows, 607 3-SNPBMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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windows, 606 4-SNP windows, 605 5-SNP windows and
604 6-SNP windows) for a total of 6060 tests. Hence, our
first approach was to construct systematic rules based on
prior information about LD and/or single SNP results to
create blocks or segments of contiguous SNPs within
which sliding window-based tests could be conducted.
The density of SNPs in this fine mapping panel was not
optimal for establishing patterns of high LD or construct-
ing large haplotype blocks; although there were 16 blocks
of LD identified using the approach of Gabriel et al. [23],
most were very small (11 had only 2 SNPs per block, 3
had 3 SNPs, and one each of 5 and 6 SNPs per block). The
physical distance across the blocks was also modest (14
were under 25 Kb, one at 136 Kb and only one at 486 Kb).
To restrict haplotype tests with sliding windows within
these haplotype blocks would have ignored much of the
data available here.
Therefore, we began with those single SNPs with marginal
levels of significance and expanded outward from these to
define segments of contiguous SNPs over which to imple-
ment sliding window haplotype analysis. There were 76
SNPs that had a positive signal (p-value < 0.05) in either
the case-control or family-based analysis. As a first step,
we created a mini-segment including all SNPs within a 1
Mb region centered around each of these 76 SNPs (i.e. 500
Kb on either side). In the next step, these 76 mini-seg-
ments were merged wherever two segments overlapped.
This resulted in 15 contiguous main segments (covering
498 SNPs), with 15 gaps (covering 111 SNPs) between
segments (where no evidence against the null hypothesis
was seen). We then performed sliding window haplotype
tests within each segment but not across segments, which
resulted in 2268 tests for each study design.
Sliding window haplotype results
Figures 1 and 2 are a compact graphical overview of all
tests performed on the family data. These figures represent
p-values from single SNP TDT tests and overall p-values
from haplotypes constructed across sliding windows of
sizes 2–6. Each test is represented by a single tile: a box
with a black outline which is as long as the number of
SNPs in the window, and the p-value of the test is repre-
sented by the color of the box. Several important points
become immediately apparent and are discussed below.
Examining p-values for any one SNP (i.e. considering the
minimum p-value across all windows that included a
SNP), reveal many SNPs had significant results (79 with
minimum p-value <0.05, 25 <0.01 and 5 <0.001). Priori-
tizing regions of interest for further follow up is not a sim-
ple task, especially since the minimum p-value should be
weighed against the number of tests yielding significant
results when setting priorities. GrASP provides a visual
Table 1: Summary of single SNP results from case-control- and family-based tests.
SNP Case-Control p-value Family-based p-value SNP location (Build 34) Gene
rs8187 0.4902 0.0006 35721356 FLJ10774
rs2001176 0.0136 0.0012 35921461 ABTB2
rs952489 0.4769 0.0078 36584163
rs17640 0.0017 0.0896 36803905
rs1323855 0.0064 0.0039 37320740 TRIM44
rs1822934 0.0132 0.0396 38997664
rs1026604 0.1875 0.0090 41508291
rs8929 0.0688 0.0072 47006838 SYT13
rs1447567 0.0050 0.5271 47431052
rs501738 0.8875 0.0039 59919843
rs734777 0.0070 0.2252 60505067
rs1675090 0.0076 0.3620 64453906
rs1212146 0.0300 0.0173 66928565 NRXN2
rs1783734 0.0788 0.0095 68013303
rs1540209 0.0263 0.0237 70451445 SUV420H1
rs1017639 0.0007 0.1615 71121458
rs1249579 0.0092 0.5639 71294225
rs873860 0.1812 0.0090 72273439 TMEM16A
rs624765 0.0031 0.7237 72480733 PPFIA1
rs534668 0.3425 0.0016 74816006 STARD10
rs519790 0.1869 0.0000 74836264 STARD10
rs1791926 0.0030 0.5864 75282569 P2RY2
rs1320646 0.0127 0.0290 78697013 GARP
rs948763 0.0049 0.2763 81161079 LOC440057
rs1151188 0.0077 0.4141 81385674
rs586607 0.4162 0.0012 84860384BMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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presentation of the results that can simplify the identifica-
tion of regions with both high significance and where
multiple tests yielded high significance. Here, we consider
regions of highest priority as those that have a building of
windows with significance across multiple SNPs.
Relying upon these patterns, five regions depicted in Fig-
ures 1 and 2 (and labelled A – E) stand out as "regions of
interest". Each of these regions contain SNPs with mini-
mum p-values that are statistically significant, multiple
windows in the region showing significance, and have a
pattern of building from smaller to larger windows until
the strength of apparent association drops off for the larg-
est haplotypes (as would be expected considering the
breakdown of the original putative causal haplotype over
physical distance).
Figures 3 and 4 present these five regions (labelled A-E) in
more detail, including evidence from the case-control
analysis, the physical location of SNPs and known genes
in this region (both features available in GrASP – either
relying on user-provided input or by querying public data-
bases of Entrez). Examining the details of chromosomal
regions using this approach can simplify the process of
identifying regions of association and prime candidate
genes. The five regions with strong patterns in the family
data also had signals of association in the case-control
data, although the two did not always align perfectly.
Graphical Assessment of sliding p-values for all tests performed on SNPs 1–303 in the family-based data with prioritized  regions of association signal (labelled A-C) Figure 1
Graphical Assessment of sliding p-values for all tests performed on SNPs 1–303 in the family-based data with prioritized 
regions of association signal (labelled A-C).BMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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Discussion
In this report we present a graphical tool for haplotype
association analysis utilizing data of dense SNPs on chro-
mosome 11q for asthma in an African American popula-
tion, and identify five regions that may include
susceptibility loci for asthma.
High throughput genotyping and dense SNP maps makes
the sliding window approach for analyzing haplotypes
appealing, and several groups have explored this
approach from a statistical [24-29] and applied perspec-
tive [1-6,30]. In this sliding window approach, windows
of varying size are examined, generally beginning with the
first SNP and moving windows down the framework map
one SNP at a time. This strategy is simple and efficient in
comprehensively screening a dense region of genotyping
for association with the trait of interest. This approach,
however, does raise problematic issues: exceedingly high
numbers of non-independent tests, the task of assimilat-
ing thousands of test results, attempting to create haplo-
types across SNPs far from each other, and prioritizing
"regions of interest" based on sometimes weak signals
from these multiple tests. Here, we provide a novel graph-
ical simplification to some of these issues in our imple-
mentation of the Graphical Assessment of Sliding P-
values (GrASP) analysis tool.
The use of graphical presentations and has proved
extremely useful in other analytical strategies for mass
amounts of data, including linkage analysis [31], linkage
disequilibrium patterns [32], identification of haplotype
block structure [23], and most commonly in high-
throughput gene expression profiling (e.g. microarray)
[33-38]. In many of these diverse applications, color rep-
resentation can quickly reveal underlying patterns. The
use of sliding haplotype windows yields high numbers of
tests; in this study sliding windows of 2–6 SNPs over 609
SNPs yielded a maximum of 3030 tests. Limiting regions
Graphical Assessment of sliding p-values for all tests performed on SNPs 304–609 in the family-based data with prioritized  regions of association signal (labelled D-E) Figure 2
Graphical Assessment of sliding p-values for all tests performed on SNPs 304–609 in the family-based data with prioritized 
regions of association signal (labelled D-E).BMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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of sliding windows can reduce the number of tests, but
summarizing 2268 tests to identify patterns of association
is still difficult. Although using a summary measure, such
as the minimum p-value for each SNP, can simplify this
issue, it would be ideal to have all test results available for
assessment without selecting sub-sets. Here too, as in the
case of LD and gene expression patterns, a graphical over-
view (as implemented in GrASP) is both practical and
effective.
The simple assimilation of all the results itself (seen in Fig-
ures 1 and 2) overcomes the task of presenting 2268 test
results simultaneously, and clearly shows most of the
regions have no evidence of statistically significant signals
(i.e. green background). However, there are several
regions with distinct signals (yellow, orange and red
cells), but only a handful of these are compelling (defined
by clusters of yellow, orange and red cells).
Setting priorities for regions of association from case-con-
trol or case-parent trio data as used here is a key step in
identifying putative asthma and atopy genes in this region
on chromosome 11q. For any single SNP, up to 21 tests of
association are performed (one single SNP test, two 2-SNP
windows that include the SNP, three 3-SNP windows,
four 4-SNP windows, five 5-SNP windows, and six 6-SNP
windows that include the SNP) using this sliding window
approach. Relying solely upon minimum p-value for each
Detailed overview of the first three regions with strongest association signals (regions A-C in Figure 1) for case-control- and  family-based tests along with SNP and known gene locations Figure 3
Detailed overview of the first three regions with strongest association signals (regions A-C in Figure 1) for case-control- and 
family-based tests along with SNP and known gene locations. Color coding of p-values are as presented in Figure 1.BMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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SNP from these tests clearly ignores the number of tests
performed. Graphically examining the strength of the sig-
nal for each SNP (the minimum p-value) and the number
of tests providing evidence at this SNP as part of increas-
ingly larger haplotypes using GrASP presents both types of
information jointly (Figures 1 and 2). Currently one can
weigh the evidence in priority regions informally, but the
application of formal rules (including aspects such as
effect size and haplotype frequencies) could be imple-
mented. Based on this approach, 5 regions can be identi-
fied as priorities for subsequent mapping, but our
prioritization scheme is not meant to rule out the few
additional regions with smaller signals (see Figures 1 and
2). How to narrow the putative region of interest is
another major question, and we show that this issue can
also be simplified with GrASP. Here, by searching for
increasingly significant haplotypes in the areas of interest
(as depicted in Figures 3 and 4), the location of the strong-
est signals given the current genotyping density is easy to
determine. This provides the investigator a reasonable
starting point for additional genotyping, particularly for
SNPs to be typed within and flanking a current block of
association.
Finally, as we were unable to use haplotype blocks to
guide our haplotype analyses, we substantially reduced
the number of sliding window tests by relying on our sin-
gle SNP results. In these data, all strong signals from the
sliding windows were centered at or around a SNP with an
individually significant association. However, considering
situations with very few single-SNP signals or extremely
dense SNP data with high LD, our rules for forming seg-
ments (within which sliding window tests are done) may
discard too much or too little data. Furthermore, limiting
haplotype tests in regions highlighted by single SNPs tests
may introduce several issues: missing regions of associa-
Detailed overview of the final two regions with strongest association signals (regions D-E in Figure 2) for case-control- and  family-based tests along with SNP and known gene locations Figure 4
Detailed overview of the final two regions with strongest association signals (regions D-E in Figure 2) for case-control- and 
family-based tests along with SNP and known gene locations. Color coding of p-values are as presented in Figure 1.BMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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tion that would only have been detected with a haplotype
test (i.e. those for which the single-SNP tests did not have
sufficient power), and perpetuation of false positives espe-
cially when limiting haplotype tests only to SNPs in tight
LD with those single SNPs yielding a significant associa-
tion. Considering issues such as these, it is more appropri-
ate that the sliding window approach should consider the
density of SNPs at hand first analyzing smaller windows
and then proceeding to larger windows where there are
signals from the smaller windows rather than restricting
windows to regions based on single-SNP results. Given
our SNP density (here relatively sparse for fine mapping),
it appears that the windowing approach should be imple-
mented only for windows of size 2–4. The 5- and 6-SNP
windows should be tested only where the smaller win-
dows reveal positive associations. This in itself would
have reduced the number of tests by an additional 864
(38%) for each analysis type. GrASP now makes this strat-
egy to reduce the number of tests for sliding window
approach easy to implement, and thereby efficient.
The five regions of priority contain many known genes as
illustrated in Figures 3 and 4. Although most of these
genes are not immediately recognized as candidates in the
pathophysiology of asthma and atopy, a few are notable.
Two genes (ELF5 and EHS) from region A encode mem-
bers of the ETS transcription factor subfamily [39], show
epithelial-specific expression, and their gene products
may act as a transcriptional repressors. These two genes
have been suggested as candidate genes for asthma in a
genome-wide linkage analysis in Tristan da Cunha
[40,41], and variants of the EHS gene were shown to be
weakly associated with asthma susceptibility in a Cauca-
sian case-control study [42,43]. The gene LRP5 in region
D encodes the low density lipoprotein receptor-related
protein 5 and has been linked to the susceptibility to oste-
oprosis and IDDM [44]. It is important to note that the
peak fine-mapping marker, D11S1337, is situated within
this locus [17]. Interestingly, about 400 kb away from
LRP5, the TCIRG1 (gene which encodes a vacuolar proton
pump H(+)-ATPase) is also included in a region of signif-
icant association. Two different gene products through
alternative splicing have been found for TCIRG1, one of
which, TIRC7, encodes a protein essential in T-cell activa-
tion, and is almost exclusively expressed in the immune
system [45].
Conclusion
In conclusion, we have demonstrated that the use of
GrASP can serve as a step towards simplifying multiple
issues in the sliding window approach for haplotype anal-
ysis: summarizing test results, setting priorities for defin-
ing regions of interest and narrowing these regions of
interest. Here, GrASP is used on fine-mapping SNP data,
but it may also assist greatly in assessing SNPs within can-
didate genes of interest and even more so in genome-
screen SNP data analysis. We have identified five regions
with strong evidence for association with asthma in these
African American subjects which contain many known
genes including a few noteworthy candidates. Most com-
pelling, is the strong evidence from region four that also
includes our peak linkage marker reported previously.
Methods
Study population
Study protocols for the Collaborative Study on the Genet-
ics of Asthma (CSGA) were approved by the Institutional
Review Boards of Johns Hopkins University School of
Medicine and Howard University College of Medicine.
Written informed consent was obtained from each of the
study subjects. A total of 89 African American case-parent
trios were included[17,21]. The ascertainment scheme
and clinical characteristics of these families have been
described in detail elsewhere [16]. Briefly, families were
ascertained through an asthmatic sib-pair and asthmatic
probands in case-parent trios. In the case-control design,
89 unrelated individuals were selected from among asth-
matic probands of 49 multiplex African American families
and 40 case-parent trios. In addition, 95 randomly
selected healthy individuals were included as a replication
study in a case-control study design. We should note that
while our sample size is limited, these data are a subset of
the original families that provided compelling evidence
for linkage and association in this region of 11q, and
therefore a good sample for fine-mapping.
Genotyping
Genetic analysis was conducted on either genomic DNAs
or DNA amplified directly from blood using multiple dis-
placement amplification (MDA) technology (Molecular
Staging Inc.) [46,47]. Genotyping was performed at the
SNP Center of the Genetic Resources Core Facility (GRCF)
at the McKusick/Nathans Institute of Genetic Medicine,
Johns Hopkins School of Medicine. Genotypes were gen-
erated on a BeadLab 1000 system [22] using the Illu-
mina™ Fine Mapping Panel #38 (Illumina OPA ID =
FM78) spanning 52 Mb on chromosome 11q (35–87 Mb
– using the Build 34 map).
Statistical methods
At the single-SNP level, the family-based association test
(FBAT) as described by Rabinowitz and Laird [48] with
the empirical variance-covariance estimator was used for
the family-based sample and in the case-control design, χ2
tests were used to test for independence between single
SNPs and disease status.
For the haplotype analysis, sliding windows of 2 – 6 SNPs
each were considered as the approach allows for compre-
hensive screening of the whole region of genotyping. InBMC Genetics 2006, 7:38 http://www.biomedcentral.com/1471-2156/7/38
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the family-based analysis, haplotype tests were performed
using methods described by Horvath et al [49] which
assumes no recombination between markers, and is anal-
ogous to the single marker multi-allelic statistic described
by Rabinowitz and Laird [48] allowing for weighting all
phased genotypes (haplotypes) possible in the family. An
EM algorithm which maximizes the likelihood of the
phased haplotype frequencies based on all observed fam-
ily genotypes and computed under the null hypothesis
was used to estimate haplotype frequencies used to obtain
these weights. For the case-control data, group-wise hap-
lotype frequencies were estimated using an EM algorithm
[50]. χ2 values were calculated for each haplotype versus
all others, and empiric significance was assessed using
10,000 permutations of the observed case-control data.
The "omnibus test" was evaluated to detect differences in
overall haplotype frequency profiles between asthmatics
and controls [50]. For both the family- and case-control
analyses only the overall test statistic was considered, i.e.
one single overall test per sliding window, and not the
individual tests of deviation from expected for each hap-
lotype.
Graphical overview of sliding windows
Graphical Assessment of Sliding P-values or GrASP, a tool
to graphically present and assess p-values from sliding
window haplotype tests, was implemented. This program
can summarize thousands of p-values from sliding win-
dow tests of variable sizes in a simple graphic that uses
varying levels of a user-specified color to indicate the
width of the sliding windows and the level of statistical
significance attained. With this tool it now becomes a sim-
ple task to identify regions/blocks of interest from these
sliding windows, based jointly on the absolute p-value of
the tests and the building of haplotypes of significance in
the region. GrASP is executed as an Excel macro, and is
written in Excel's built-in version of Visual Basic for Appli-
cations. It uses as input, a summary file that contains the
test results stored in simple format (SNP order, first SNP
of each window and p-values from windows of varying
sizes) that is easily constructed from analysis output con-
sidering the repetitive nature of the output results. GrASP
also illustrates SNP location and the location of known
genes in the region as a physical track that is drawn either
using user-provided input, or by querying the public data-
bases of Entrez. GrASP is freely available for use at: http:/
/research.nhgri.nih.gov/GrASP/.
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